Evidence map›Paper›PMID 37576022›Full record

ArticleFrontiers in neurology2023

An

Ling Li, Lamei Yuan, Wen Zheng, Yan Yang, Xiong Deng, Zhi Song, Hao Deng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ling Li *Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China.
Lamei Yuan *Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China.
Wen ZhengDepartment of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Yan YangDepartment of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Xiong DengCenter for Experimental Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.
Zhi SongDepartment of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Hao DengHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic epilepsy with febrile seizures plus (GEFSP) is a familial epileptic syndrome that is genetically heterogeneous and inherited in an autosomal dominant form in most cases. To date, at least seven genes have been reported to associate with GEFSP. This study aimed to identify the disease-causing variant in a Chinese Tujia ethnic family with GEFSP by using whole exome sequencing, Sanger sequencing, and

Indexed as

genetic diagnosesgenetic epilepsy with febrile seizures plusmissense variantSCN1Awhole exome sequencing

Identifiers

PMID37576022
PMCPMC10412811
OpenAlexW4385367528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.